-
1
-
-
84879799217
-
Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death
-
Aires V, Limagne E, Cotte AK, Latruffe N, Ghiringhelli F, Delmas D (2013). Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death. Mol Nutr Food Res 57: 1170–1181.
-
(2013)
Mol Nutr Food Res
, vol.57
, pp. 1170-1181
-
-
Aires, V.1
Limagne, E.2
Cotte, A.K.3
Latruffe, N.4
Ghiringhelli, F.5
Delmas, D.6
-
2
-
-
77950676607
-
Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans- resveratrol in knockout mice
-
Alfaras I, Pérez M, Juan ME, Merino G, Prieto JG, Planas JM, et al. (2010). Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans- resveratrol in knockout mice. J Agric Food Chem 58: 4523–4528.
-
(2010)
J Agric Food Chem
, vol.58
, pp. 4523-4528
-
-
Alfaras, I.1
Pérez, M.2
Juan, M.E.3
Merino, G.4
Prieto, J.G.5
Planas, J.M.6
-
3
-
-
84976527211
-
Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats
-
Taylor & Francis
-
Ali MHH, Messiha BAS, Abdel-Latif HA-T (2015). Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. Pharm Biol 54: 1198–1208. Taylor & Francis.
-
(2015)
Pharm Biol
, vol.54
, pp. 1198-1208
-
-
Ali, M.H.H.1
Messiha, B.A.S.2
Abdel-Latif, H.A.-T.3
-
4
-
-
84939952998
-
Neuroprotective action of resveratrol
-
Elsevier B.V
-
Bastianetto S, Ménard C, Quirion R (2015). Neuroprotective action of resveratrol. BBA Mol Basis Dis 1852: 1195–1201.Elsevier B.V.
-
(2015)
BBA Mol Basis Dis
, vol.1852
, pp. 1195-1201
-
-
Bastianetto, S.1
Ménard, C.2
Quirion, R.3
-
5
-
-
84929466847
-
Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers
-
Bedada SK, Nearati P (2015). Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers. Phyther Res 29: 701–706.
-
(2015)
Phyther Res
, vol.29
, pp. 701-706
-
-
Bedada, S.K.1
Nearati, P.2
-
6
-
-
85012084342
-
Resveratrol enhances the bioavailability of fexofenadine in healthy human male volunteers : involvement of P-glycoprotein inhibition
-
Bedada SK, Yakkanti SA, Neerati P (2014). Resveratrol enhances the bioavailability of fexofenadine in healthy human male volunteers : involvement of P-glycoprotein inhibition. J Bioequiv Availab 6: 158–163.
-
(2014)
J Bioequiv Availab
, vol.6
, pp. 158-163
-
-
Bedada, S.K.1
Yakkanti, S.A.2
Neerati, P.3
-
7
-
-
67649221173
-
Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes
-
Beedanagari SR, Bebenek I, Bui P, Hankinson O (2009). Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicol Sci 110: 61–67.
-
(2009)
Toxicol Sci
, vol.110
, pp. 61-67
-
-
Beedanagari, S.R.1
Bebenek, I.2
Bui, P.3
Hankinson, O.4
-
8
-
-
84865181393
-
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
-
Elsevier Inc
-
Bhatt JK, Thomas S, Nanjan MJ (2012). Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res 32: 537–541, Elsevier Inc.
-
(2012)
Nutr Res
, vol.32
, pp. 537-541
-
-
Bhatt, J.K.1
Thomas, S.2
Nanjan, M.J.3
-
9
-
-
84925396164
-
Metabolic effects of resveratrol: addressing the controversies
-
Bitterman JL, Chung JH (2015). Metabolic effects of resveratrol: addressing the controversies. Cell Mol Life Sci 72: 1473–1488.
-
(2015)
Cell Mol Life Sci
, vol.72
, pp. 1473-1488
-
-
Bitterman, J.L.1
Chung, J.H.2
-
10
-
-
84873368632
-
In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota
-
Bode LM, Bunzel D, Huch M, Cho G-S, Ruhland D, Bunzel M, et al. (2013). In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr 97: 295–309.
-
(2013)
Am J Clin Nutr
, vol.97
, pp. 295-309
-
-
Bode, L.M.1
Bunzel, D.2
Huch, M.3
Cho, G.-S.4
Ruhland, D.5
Bunzel, M.6
-
11
-
-
34250901592
-
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
-
Boocock D, Faust G, Patel K, Schinas A, Brown V, Ducharme M, Booth T, Crowell J, Perloff M, Gescher A, Steward W, Brenner D (2007). Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol biomarkers Prev 16: 1246–1252.
-
(2007)
Cancer Epidemiol biomarkers Prev
, vol.16
, pp. 1246-1252
-
-
Boocock, D.1
Faust, G.2
Patel, K.3
Schinas, A.4
Brown, V.5
Ducharme, M.6
Booth, T.7
Crowell, J.8
Perloff, M.9
Gescher, A.10
Steward, W.11
Brenner, D.12
-
12
-
-
80052910300
-
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
-
Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, et al. (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106: 383–389.
-
(2011)
Br J Nutr
, vol.106
, pp. 383-389
-
-
Brasnyó, P.1
Molnár, G.A.2
Mohás, M.3
Markó, L.4
Laczy, B.5
Cseh, J.6
-
13
-
-
33645568250
-
Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms
-
Brill SS, Furimsky AM, Ho MN, Furniss MJ, Li Y, Green AG, et al. (2006). Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms. J Pharm Pharmacol 58: 469–479.
-
(2006)
J Pharm Pharmacol
, vol.58
, pp. 469-479
-
-
Brill, S.S.1
Furimsky, A.M.2
Ho, M.N.3
Furniss, M.J.4
Li, Y.5
Green, A.G.6
-
14
-
-
78549288940
-
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis
-
Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, et al. (2010). Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70: 9003–9011.
-
(2010)
Cancer Res
, vol.70
, pp. 9003-9011
-
-
Brown, V.A.1
Patel, K.R.2
Viskaduraki, M.3
Crowell, J.A.4
Perloff, M.5
Booth, T.D.6
-
15
-
-
4444267291
-
Crystal structure of quinone reductase 2 in complex with resveratrol
-
Buryanovskyy L, Fu Y, Boyd M, Ma Y, Hsieh TC, Wu JM, et al. (2004). Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43: 11417–11426.
-
(2004)
Biochemistry
, vol.43
, pp. 11417-11426
-
-
Buryanovskyy, L.1
Fu, Y.2
Boyd, M.3
Ma, Y.4
Hsieh, T.C.5
Wu, J.M.6
-
16
-
-
84938322187
-
Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice
-
Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A, et al. (2015) Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med 7:298ra117.
-
(2015)
Sci Transl Med
, vol.7
, pp. 298ra117
-
-
Cai, H.1
Scott, E.2
Kholghi, A.3
Andreadi, C.4
Rufini, A.5
Karmokar, A.6
-
17
-
-
58149500695
-
Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice
-
Canistro D, Bonamassa B, Pozzetti L, Sapone A, Abdel-Rahman SZ, Biagi GL, et al. (2009). Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice. Food Chem Toxicol 47: 454–461.
-
(2009)
Food Chem Toxicol
, vol.47
, pp. 454-461
-
-
Canistro, D.1
Bonamassa, B.2
Pozzetti, L.3
Sapone, A.4
Abdel-Rahman, S.Z.5
Biagi, G.L.6
-
19
-
-
84895175096
-
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity
-
Cavalieri E, Rogan E (2014). The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Mol Aspects Med 36: 1–55.
-
(2014)
Mol Aspects Med
, vol.36
, pp. 1-55
-
-
Cavalieri, E.1
Rogan, E.2
-
20
-
-
79958761363
-
Resveratrol - pills to replace a healthy diet?
-
Chachay VS, Kirkpatrick CMJ, Hickman IJ, Ferguson M, Prins JB, Martin JH (2011). Resveratrol - pills to replace a healthy diet? Br J Clin Pharmacol 72: 27–38.
-
(2011)
Br J Clin Pharmacol
, vol.72
, pp. 27-38
-
-
Chachay, V.S.1
Kirkpatrick, C.M.J.2
Hickman, I.J.3
Ferguson, M.4
Prins, J.B.5
Martin, J.H.6
-
21
-
-
84918791665
-
Resveratrol does not benefit patients with nonalcoholic fatty liver disease
-
Elsevier, Inc
-
Chachay VS, Macdonald GA., Martin JH, Whitehead JP, O'Moore–Sullivan TM, Lee P, et al. (2014) Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 12:2092–2103.e6, Elsevier, Inc.
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. 2092-2103.e6
-
-
Chachay, V.S.1
Macdonald, G.A.2
Martin, J.H.3
Whitehead, J.P.4
O'Moore–Sullivan, T.M.5
Lee, P.6
-
22
-
-
0034634252
-
Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4
-
Chan WK, Delucchi AB (2000). Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Sci 67: 3103–3112.
-
(2000)
Life Sci
, vol.67
, pp. 3103-3112
-
-
Chan, W.K.1
Delucchi, A.B.2
-
23
-
-
0346728729
-
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
-
Chan LM, Lowes S, Hirst BH (2004). The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21: 25–51.
-
(2004)
Eur J Pharm Sci
, vol.21
, pp. 25-51
-
-
Chan, L.M.1
Lowes, S.2
Hirst, B.H.3
-
24
-
-
0035192944
-
Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2
-
Chang TK, Chen J, Lee WB (2001). Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J Pharmacol Exp Ther 299: 874–882.
-
(2001)
J Pharmacol Exp Ther
, vol.299
, pp. 874-882
-
-
Chang, T.K.1
Chen, J.2
Lee, W.B.3
-
25
-
-
55849151295
-
In vitro inhibition of rat CYP1A1 and CYP1A2 by piceatannol, a hydroxylated metabolite of trans-resveratrol
-
Chang TKH, Chen J, Yu C-T (2007). In vitro inhibition of rat CYP1A1 and CYP1A2 by piceatannol, a hydroxylated metabolite of trans-resveratrol. Drug Metab Lett 1: 13–16.
-
(2007)
Drug Metab Lett
, vol.1
, pp. 13-16
-
-
Chang, T.K.H.1
Chen, J.2
Yu, C.-T.3
-
26
-
-
6444222048
-
Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells
-
Chen Z-H, Hurh Y-J, Na H-K, Kim J-H, Chun Y-J, Kim D-H, et al. (2004). Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 25: 2005–13.
-
(2004)
Carcinogenesis
, vol.25
, pp. 2005-2013
-
-
Chen, Z.-H.1
Hurh, Y.-J.2
Na, H.-K.3
Kim, J.-H.4
Chun, Y.-J.5
Kim, D.-H.6
-
27
-
-
84984972752
-
Trans -Resveratrol Enhances the Anticoagulant Activity of Warfarin
-
Chiba T, Kimura Y, Suzuki S, Tatefuji T, Umegaki K (2016). Trans -Resveratrol Enhances the Anticoagulant Activity of Warfarin. J Atheroscler Thromb 23: 1099–1110.
-
(2016)
J Atheroscler Thromb
, vol.23
, pp. 1099-1110
-
-
Chiba, T.1
Kimura, Y.2
Suzuki, S.3
Tatefuji, T.4
Umegaki, K.5
-
28
-
-
62649097859
-
Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol
-
Choi JS, Choi BC, Kang KW (2009). Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol. Pharmazie 64: 49–52.
-
(2009)
Pharmazie
, vol.64
, pp. 49-52
-
-
Choi, J.S.1
Choi, B.C.2
Kang, K.W.3
-
29
-
-
77956412951
-
Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study
-
Chow HHS, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, et al. (2010). Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res 3: 1168–1175.
-
(2010)
Cancer Prev Res
, vol.3
, pp. 1168-1175
-
-
Chow, H.H.S.1
Garland, L.L.2
Hsu, C.H.3
Vining, D.R.4
Chew, W.M.5
Miller, J.A.6
-
30
-
-
84906735201
-
A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones
-
Chow H-H, Garland LL, Heckman-Stoddard BM, Hsu C-H, Butler VD, Cordova CA, et al. (2014). A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J Transl Med 12: 223.
-
(2014)
J Transl Med
, vol.12
, pp. 223
-
-
Chow, H.-H.1
Garland, L.L.2
Heckman-Stoddard, B.M.3
Hsu, C.-H.4
Butler, V.D.5
Cordova, C.A.6
-
31
-
-
84907590384
-
The effect of resveratrol and its methylthio-derivatives on EGFR and Stat3 activation in human HaCaT and A431 cells
-
Cichocki M, Szaefer H, Krajka-Kuźniak V, Baer-Dubowska W (2014). The effect of resveratrol and its methylthio-derivatives on EGFR and Stat3 activation in human HaCaT and A431 cells. Mol Cell Biochem 396: 221–228.
-
(2014)
Mol Cell Biochem
, vol.396
, pp. 221-228
-
-
Cichocki, M.1
Szaefer, H.2
Krajka-Kuźniak, V.3
Baer-Dubowska, W.4
-
32
-
-
0032862195
-
Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol
-
Ciolino HP, Yeh GC (1999). Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56: 760–767.
-
(1999)
Mol Pharmacol
, vol.56
, pp. 760-767
-
-
Ciolino, H.P.1
Yeh, G.C.2
-
33
-
-
0032535055
-
Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor
-
Ciolino HP, Daschner PJ, Yeh GC (1998). Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58: 5707–5712.
-
(1998)
Cancer Res
, vol.58
, pp. 5707-5712
-
-
Ciolino, H.P.1
Daschner, P.J.2
Yeh, G.C.3
-
34
-
-
84886015444
-
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans
-
Cottart CH, Nivet-Antoine V, Beaudeux JL (2014). Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans. Mol Nutr Food Res 58: 7–21.
-
(2014)
Mol Nutr Food Res
, vol.58
, pp. 7-21
-
-
Cottart, C.H.1
Nivet-Antoine, V.2
Beaudeux, J.L.3
-
35
-
-
84860131782
-
Pilot study of resveratrol in older adults with impaired glucose tolerance
-
Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, et al. (2012). Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67: 1307–1312.
-
(2012)
J Gerontol A Biol Sci Med Sci
, vol.67
, pp. 1307-1312
-
-
Crandall, J.P.1
Oram, V.2
Trandafirescu, G.3
Reid, M.4
Kishore, P.5
Hawkins, M.6
-
36
-
-
10044243554
-
Resveratrol-associated renal toxicity
-
Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS (2004). Resveratrol-associated renal toxicity. Toxicol Sci 82: 614–619.
-
(2004)
Toxicol Sci
, vol.82
, pp. 614-619
-
-
Crowell, J.A.1
Korytko, P.J.2
Morrissey, R.L.3
Booth, T.D.4
Levine, B.S.5
-
37
-
-
84888200040
-
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men
-
Dash S, Xiao C, Morgantini C, Szeto L, Lewis GF (2013). High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men. Arterioscler Thromb Vasc Biol 33: 2895–901.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 2895-2901
-
-
Dash, S.1
Xiao, C.2
Morgantini, C.3
Szeto, L.4
Lewis, G.F.5
-
38
-
-
84909578260
-
Resveratrol Suppresses the Inducible Expression of CYP3A4 Through the Pregnane X Receptor
-
Deng R, Xu C, Chen X, Chen P, Wang Y, Zhou X, et al. (2014). Resveratrol Suppresses the Inducible Expression of CYP3A4 Through the Pregnane X Receptor. J Pharmacol Sci 126: 146–154.
-
(2014)
J Pharmacol Sci
, vol.126
, pp. 146-154
-
-
Deng, R.1
Xu, C.2
Chen, X.3
Chen, P.4
Wang, Y.5
Zhou, X.6
-
41
-
-
67549131188
-
Energy homeostasis and cancer prevention: the AMP-activated protein kinase
-
Fay JR, Steele V, Crowell JA (2009). Energy homeostasis and cancer prevention: the AMP-activated protein kinase. Cancer Prev Res (Phila) 2: 301–309.
-
(2009)
Cancer Prev Res (Phila)
, vol.2
, pp. 301-309
-
-
Fay, J.R.1
Steele, V.2
Crowell, J.A.3
-
42
-
-
84864041649
-
CYP1B1 and hormone-induced cancer
-
Elsevier Ireland Ltd
-
Gajjar K, Martin-Hirsch PL, Martin FL (2012). CYP1B1 and hormone-induced cancer. Cancer Lett 324: 13–30, Elsevier Ireland Ltd.
-
(2012)
Cancer Lett
, vol.324
, pp. 13-30
-
-
Gajjar, K.1
Martin-Hirsch, P.L.2
Martin, F.L.3
-
45
-
-
84907878785
-
Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications
-
Guillemette C, Lévesque É, Rouleau M (2014). Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications. Clin Pharmacol Ther 96: 324–339.
-
(2014)
Clin Pharmacol Ther
, vol.96
, pp. 324-339
-
-
Guillemette, C.1
Lévesque, É.2
Rouleau, M.3
-
46
-
-
55849119571
-
Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats
-
Hong SP, Choi DH, Choi JS (2008). Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats. Cardiovasc Ther 26: 269–275.
-
(2008)
Cardiovasc Ther
, vol.26
, pp. 269-275
-
-
Hong, S.P.1
Choi, D.H.2
Choi, J.S.3
-
47
-
-
77954331919
-
Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites
-
Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, Van Breemen RB, et al. (2010). Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem 53: 5033–5043.
-
(2010)
J Med Chem
, vol.53
, pp. 5033-5043
-
-
Hoshino, J.1
Park, E.J.2
Kondratyuk, T.P.3
Marler, L.4
Pezzuto, J.M.5
Van Breemen, R.B.6
-
48
-
-
84898410785
-
Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
-
Huang F, Wu XN, Chen J, Wang WX, Lu ZF (2014). Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. Exp Ther Med 7: 1611–1616.
-
(2014)
Exp Ther Med
, vol.7
, pp. 1611-1616
-
-
Huang, F.1
Wu, X.N.2
Chen, J.3
Wang, W.X.4
Lu, Z.F.5
-
49
-
-
0036324035
-
Effects of plant-derived phenols on rat liver cytochrome P450 2B1 activity
-
Huynh HT, Teel RW (2002). Effects of plant-derived phenols on rat liver cytochrome P450 2B1 activity. Anticancer Res 22: 1699–1703.
-
(2002)
Anticancer Res
, vol.22
, pp. 1699-1703
-
-
Huynh, H.T.1
Teel, R.W.2
-
50
-
-
13544249943
-
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
-
Ingelman-Sundberg M (2005). Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5: 6–13.
-
(2005)
Pharmacogenomics J
, vol.5
, pp. 6-13
-
-
Ingelman-Sundberg, M.1
-
51
-
-
79957563746
-
Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells
-
Iwuchukwu OF, Tallarida RJ, Nagar S (2011). Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells. Life Sci 88: 1047–1054.
-
(2011)
Life Sci
, vol.88
, pp. 1047-1054
-
-
Iwuchukwu, O.F.1
Tallarida, R.J.2
Nagar, S.3
-
53
-
-
84930885516
-
Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats
-
Javkhedkar AA, Quiroz Y, Rodriguez-Iturbe B, Vaziri ND, Lokhandwala MF, Banday AA (2015). Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 308: R840–846.
-
(2015)
Am J Physiol Regul Integr Comp Physiol
, vol.308
, pp. R840-846
-
-
Javkhedkar, A.A.1
Quiroz, Y.2
Rodriguez-Iturbe, B.3
Vaziri, N.D.4
Lokhandwala, M.F.5
Banday, A.A.6
-
54
-
-
84937972337
-
CYP2E1 epigenetic regulation in chronic, low-level toluene exposure: relationship with oxidative stress and smoking habit
-
Elsevier Inc
-
Jiménez-Garza O, Baccarelli AA., Byun H-M, Márquez-Gamiño S, Barrón-Vivanco BS, Albores A (2015) CYP2E1 epigenetic regulation in chronic, low-level toluene exposure: relationship with oxidative stress and smoking habit. Toxicol Appl Pharmacol 286:207–215, Elsevier Inc.
-
(2015)
Toxicol Appl Pharmacol
, vol.286
, pp. 207-215
-
-
Jiménez-Garza, O.1
Baccarelli, A.A.2
Byun, H.-M.3
Márquez-Gamiño, S.4
Barrón-Vivanco, B.S.5
Albores, A.6
-
55
-
-
19944434201
-
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment
-
Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, et al. (2005). CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 97: 30–39.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 30-39
-
-
Jin, Y.1
Desta, Z.2
Stearns, V.3
Ward, B.4
Ho, H.5
Lee, K.H.6
-
56
-
-
84907550784
-
Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice
-
Kalash R, Berhane H, Au J, Rhieu BH, Epperly MW, Goff J, et al. (2014). Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice. In Vivo 28: 147–171.
-
(2014)
In Vivo
, vol.28
, pp. 147-171
-
-
Kalash, R.1
Berhane, H.2
Au, J.3
Rhieu, B.H.4
Epperly, M.W.5
Goff, J.6
-
57
-
-
70350048926
-
Impact of OATP transporters on pharmacokinetics
-
Kalliokoski A, Niemi M (2009). Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158: 693–705.
-
(2009)
Br J Pharmacol
, vol.158
, pp. 693-705
-
-
Kalliokoski, A.1
Niemi, M.2
-
58
-
-
0042738877
-
Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study
-
Kidd LCR, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA (2003). Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J cancer Prev Off J Eur Cancer Prev Organ ECP 12: 317–320.
-
(2003)
Eur J cancer Prev Off J Eur Cancer Prev Organ ECP
, vol.12
, pp. 317-320
-
-
Kidd, L.C.R.1
Woodson, K.2
Taylor, P.R.3
Albanes, D.4
Virtamo, J.5
Tangrea, J.A.6
-
59
-
-
84887140160
-
Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin
-
Elsevier B.V
-
Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, et al. (2014). Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochim Biophys Acta - Gen Subj 1840: 615–625, Elsevier B.V.
-
(2014)
Biochim Biophys Acta - Gen Subj
, vol.1840
, pp. 615-625
-
-
Kim, T.H.1
Shin, Y.J.2
Won, A.J.3
Lee, B.M.4
Choi, W.S.5
Jung, J.H.6
-
60
-
-
84907208914
-
GST gene polymorphisms and the risk of colorectal cancer development
-
Klusek J, Głuszek S, Klusek J (2014) GST gene polymorphisms and the risk of colorectal cancer development. Contemp Oncol (Poznań, Poland) 18:219–21.
-
(2014)
Contemp Oncol (Poznań, Poland)
, vol.18
, pp. 219-221
-
-
Klusek, J.1
Głuszek, S.2
Klusek, J.3
-
61
-
-
84983182618
-
Cytochrome P450 induction properties of food and herbal-derived compounds using a novel multiplex RT-qPCR in vitro assay, a drug-food interaction prediction tool
-
Koe XF, Tengku Muhammad TS, Chong AS-C, Wahab HA, Tan ML (2014). Cytochrome P450 induction properties of food and herbal-derived compounds using a novel multiplex RT-qPCR in vitro assay, a drug-food interaction prediction tool. Food Sci Nutr 2: 500–520.
-
(2014)
Food Sci Nutr
, vol.2
, pp. 500-520
-
-
Koe, X.F.1
Tengku Muhammad, T.S.2
Chong, A.S.-C.3
Wahab, H.A.4
Tan, M.L.5
-
63
-
-
0035501476
-
Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells
-
Lee JE, Safe S (2001). Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells. Biochem Pharmacol 62: 1113–1124.
-
(2001)
Biochem Pharmacol
, vol.62
, pp. 1113-1124
-
-
Lee, J.E.1
Safe, S.2
-
64
-
-
84925424159
-
Resveratrol and obesity: can resveratrol relieve metabolic disturbances?
-
Elsevier B.V
-
de Ligt M, Timmers S, Schrauwen P (2015). Resveratrol and obesity: can resveratrol relieve metabolic disturbances? Biochim Biophys Acta - Mol Basis Dis 1852: 1137–1144, Elsevier B.V.
-
(2015)
Biochim Biophys Acta - Mol Basis Dis
, vol.1852
, pp. 1137-1144
-
-
de Ligt, M.1
Timmers, S.2
Schrauwen, P.3
-
65
-
-
2942534473
-
Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells
-
Liu J, Wang Q, Wu DC, Wang XW, Sun Y, Chen XY, et al. (2004). Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells. Neurosci Lett 363: 257–261.
-
(2004)
Neurosci Lett
, vol.363
, pp. 257-261
-
-
Liu, J.1
Wang, Q.2
Wu, D.C.3
Wang, X.W.4
Sun, Y.5
Chen, X.Y.6
-
66
-
-
84878117701
-
Pi-Pi Stacking mediated drug-drug interactions in human CYP2E1
-
Liu Y, Liu BY, Hao P, Li X, Li YX, Wang JF (2013). Pi-Pi Stacking mediated drug-drug interactions in human CYP2E1. Proteins Struct Funct Bioinforma 81: 945–954.
-
(2013)
Proteins Struct Funct Bioinforma
, vol.81
, pp. 945-954
-
-
Liu, Y.1
Liu, B.Y.2
Hao, P.3
Li, X.4
Li, Y.X.5
Wang, J.F.6
-
67
-
-
84930459950
-
Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice
-
Liu Y, Wu Y, Yu Y, Cao C, Zhang J, Li K, et al. (2015). Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice. Hum Exp Toxicol 34: 620–627.
-
(2015)
Hum Exp Toxicol
, vol.34
, pp. 620-627
-
-
Liu, Y.1
Wu, Y.2
Yu, Y.3
Cao, C.4
Zhang, J.5
Li, K.6
-
68
-
-
60549118140
-
Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells
-
Lu F, Zahid M, Wang C, Saeed M, Cavalieri EL, Rogan EG (2008). Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res 1: 135–145.
-
(2008)
Cancer Prev Res
, vol.1
, pp. 135-145
-
-
Lu, F.1
Zahid, M.2
Wang, C.3
Saeed, M.4
Cavalieri, E.L.5
Rogan, E.G.6
-
69
-
-
84870056099
-
Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1)
-
Mayhoub AS, Marler L, Kondratyuk TP, Park EJ, Pezzuto JM, Cushman M (2012). Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1). Bioorganic Med Chem 20: 7030–7039.
-
(2012)
Bioorganic Med Chem
, vol.20
, pp. 7030-7039
-
-
Mayhoub, A.S.1
Marler, L.2
Kondratyuk, T.P.3
Park, E.J.4
Pezzuto, J.M.5
Cushman, M.6
-
70
-
-
33645111448
-
Glutathione S-transferase polymorphisms: cancer incidence and therapy
-
McIlwain CC, Townsend DM, Tew KD (2006). Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25: 1639–1648.
-
(2006)
Oncogene
, vol.25
, pp. 1639-1648
-
-
McIlwain, C.C.1
Townsend, D.M.2
Tew, K.D.3
-
71
-
-
84911393595
-
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
-
Mary Ann Liebert, Inc
-
Méndez-del Villar M, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG, Lizárraga-Valdez R (2014). Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. Metab Syndr Relat Disord 12: 497–501, Mary Ann Liebert, Inc.
-
(2014)
Metab Syndr Relat Disord
, vol.12
, pp. 497-501
-
-
Méndez-del Villar, M.1
González-Ortiz, M.2
Martínez-Abundis, E.3
Pérez-Rubio, K.G.4
Lizárraga-Valdez, R.5
-
72
-
-
31544471832
-
Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1
-
Miksits M, Maier-Salamon A, Aust S, Thalhammer T, Reznicek G, Kunert O, et al. (2005). Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35: 1101–1119.
-
(2005)
Xenobiotica
, vol.35
, pp. 1101-1119
-
-
Miksits, M.1
Maier-Salamon, A.2
Aust, S.3
Thalhammer, T.4
Reznicek, G.5
Kunert, O.6
-
73
-
-
0038085651
-
Effect of natural phenols on the catalytic activity of cytochrome P450 2E1
-
Mikstacka R, Gnojkowski J, Baer-Dubowska W (2002). Effect of natural phenols on the catalytic activity of cytochrome P450 2E1. Acta Biochim Pol 49: 917–925.
-
(2002)
Acta Biochim Pol
, vol.49
, pp. 917-925
-
-
Mikstacka, R.1
Gnojkowski, J.2
Baer-Dubowska, W.3
-
74
-
-
79952074453
-
Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities
-
Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM (2011). Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 120: 49–75.
-
(2011)
Toxicol Sci
, vol.120
, pp. 49-75
-
-
Omiecinski, C.J.1
Vanden Heuvel, J.P.2
Perdew, G.H.3
Peters, J.M.4
-
75
-
-
84966671739
-
Synthesis of Resveratrol Derivatives and in Vitro Screening for Potential Cancer Chemopreventive Activities
-
Orsini F, Verotta L, Klimo K, Gerhäuser C (2016). Synthesis of Resveratrol Derivatives and in Vitro Screening for Potential Cancer Chemopreventive Activities. Arch Pharm (Weinheim) 349: 414–427.
-
(2016)
Arch Pharm (Weinheim)
, vol.349
, pp. 414-427
-
-
Orsini, F.1
Verotta, L.2
Klimo, K.3
Gerhäuser, C.4
-
76
-
-
84885454938
-
Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence
-
Patel KR, Andreadi C, Britton RG, Horner-Glister E, Karmokar A, Sale S, et al. (2013) Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci Transl Med 5:205ra133.
-
(2013)
Sci Transl Med
, vol.5
, pp. 205ra133
-
-
Patel, K.R.1
Andreadi, C.2
Britton, R.G.3
Horner-Glister, E.4
Karmokar, A.5
Sale, S.6
-
77
-
-
84455174605
-
Bupropion hydroxylation as a selective marker of rat CYP2B1 catalytic activity
-
Pekthong D, Desbans C, Martin H, Richert L (2012). Bupropion hydroxylation as a selective marker of rat CYP2B1 catalytic activity. Drug Metab Dispos 40: 32–38.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 32-38
-
-
Pekthong, D.1
Desbans, C.2
Martin, H.3
Richert, L.4
-
78
-
-
0035976379
-
Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components
-
Piver B, Berthou F, Dreano Y, Lucas D (2001). Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol Lett 125: 83–91.
-
(2001)
Toxicol Lett
, vol.125
, pp. 83-91
-
-
Piver, B.1
Berthou, F.2
Dreano, Y.3
Lucas, D.4
-
79
-
-
0037666303
-
Differential inhibition of human cytochrome P450 enzymes by ε-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages
-
Piver B, Berthou F, Dreano Y, Lucas D (2003). Differential inhibition of human cytochrome P450 enzymes by ε-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages. Life Sci 73: 1199–1213.
-
(2003)
Life Sci
, vol.73
, pp. 1199-1213
-
-
Piver, B.1
Berthou, F.2
Dreano, Y.3
Lucas, D.4
-
80
-
-
27844486110
-
Modulation of xenobiotic metabolising enzymes by anticarcinogens—focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis
-
Pool-Zobel B, Veeriah S, Bohmer FD (2005). Modulation of xenobiotic metabolising enzymes by anticarcinogens—focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res - Fundam Mol Mech Mutagen 591: 74–92.
-
(2005)
Mutat Res - Fundam Mol Mech Mutagen
, vol.591
, pp. 74-92
-
-
Pool-Zobel, B.1
Veeriah, S.2
Bohmer, F.D.3
-
81
-
-
84922458212
-
Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death
-
Elsevier Ltd
-
Posadino AM, Cossu A, Giordo R, Zinellu A, Sotgia S, Vardeu A, et al. (2015). Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death. Food Chem Toxicol 78: 10–6, Elsevier Ltd.
-
(2015)
Food Chem Toxicol
, vol.78
, pp. 10-16
-
-
Posadino, A.M.1
Cossu, A.2
Giordo, R.3
Zinellu, A.4
Sotgia, S.5
Vardeu, A.6
-
82
-
-
18344372908
-
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1
-
Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, et al. (2002). The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86: 774–778.
-
(2002)
Br J Cancer
, vol.86
, pp. 774-778
-
-
Potter, G.A.1
Patterson, L.H.2
Wanogho, E.3
Perry, P.J.4
Butler, P.C.5
Ijaz, T.6
-
83
-
-
84875431034
-
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition
-
Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, et al. (2013). High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62: 1186–1195.
-
(2013)
Diabetes
, vol.62
, pp. 1186-1195
-
-
Poulsen, M.M.1
Vestergaard, P.F.2
Clasen, B.F.3
Radko, Y.4
Christensen, L.P.5
Stødkilde-Jørgensen, H.6
-
84
-
-
84901654102
-
Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity
-
Qiao Y, Sun J, Xia S, Tang X, Shi Y, Le G (2014). Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct 5: 1241.
-
(2014)
Food Funct
, vol.5
, pp. 1241
-
-
Qiao, Y.1
Sun, J.2
Xia, S.3
Tang, X.4
Shi, Y.5
Le, G.6
-
85
-
-
84961289051
-
Caloric restriction, resveratrol and melatonin: role of SIRT1 and implications for aging and related-diseases
-
Elsevier Ireland Ltd
-
Ramis MR, Esteban S, Miralles A, Tan D-X, Reiter RJ (2015) Caloric restriction, resveratrol and melatonin: role of SIRT1 and implications for aging and related-diseases. Mech Ageing Dev 146–148:28–41, Elsevier Ireland Ltd.
-
(2015)
Mech Ageing Dev
, vol.146-148
, pp. 28-41
-
-
Ramis, M.R.1
Esteban, S.2
Miralles, A.3
Tan, D.-X.4
Reiter, R.J.5
-
86
-
-
84907481602
-
Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells
-
Riha J, Brenner S, Böhmdorfer M, Giessrigl B, Pignitter M, Schueller K, et al. (2014). Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells. Mol Nutr Food Res 58: 1830–1842.
-
(2014)
Mol Nutr Food Res
, vol.58
, pp. 1830-1842
-
-
Riha, J.1
Brenner, S.2
Böhmdorfer, M.3
Giessrigl, B.4
Pignitter, M.5
Schueller, K.6
-
87
-
-
0035142865
-
Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
-
Rochat B, Morsman JM, Murray GI, Figg WD, McLeod HL (2001). Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? J Pharmacol Exp Ther 296: 537–541.
-
(2001)
J Pharmacol Exp Ther
, vol.296
, pp. 537-541
-
-
Rochat, B.1
Morsman, J.M.2
Murray, G.I.3
Figg, W.D.4
McLeod, H.L.5
-
88
-
-
84922382285
-
Investigation into the formation of PAHs in foods prepared in the home to determine the effects of frying, grilling, barbecuing, toasting and roasting
-
Rose M, Holland J, Dowding A, Petch SRG, White S, Fernandes A, et al. (2015). Investigation into the formation of PAHs in foods prepared in the home to determine the effects of frying, grilling, barbecuing, toasting and roasting. Food Chem Toxicol 78: 1–9.
-
(2015)
Food Chem Toxicol
, vol.78
, pp. 1-9
-
-
Rose, M.1
Holland, J.2
Dowding, A.3
Petch, S.R.G.4
White, S.5
Fernandes, A.6
-
89
-
-
84887615201
-
Anti-estrogenic activity of a human resveratrol metabolite
-
Ruotolo R, Calani L, Fietta E, Brighenti F, Crozier A, Meda C, et al. (2013). Anti-estrogenic activity of a human resveratrol metabolite. Nutr Metab Cardiovasc Dis 23: 1086–1092.
-
(2013)
Nutr Metab Cardiovasc Dis
, vol.23
, pp. 1086-1092
-
-
Ruotolo, R.1
Calani, L.2
Fietta, E.3
Brighenti, F.4
Crozier, A.5
Meda, C.6
-
90
-
-
84870284476
-
Plasma Cytokine Concentrations in Workers Exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
-
Saberi Hosnijeh F, Boers D, Portengen L, Bueno-de-Mesquita HB, Heederik D, Vermeulen R (2012). Plasma Cytokine Concentrations in Workers Exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Front Oncol 2: 37.
-
(2012)
Front Oncol
, vol.2
, pp. 37
-
-
Saberi Hosnijeh, F.1
Boers, D.2
Portengen, L.3
Bueno-de-Mesquita, H.B.4
Heederik, D.5
Vermeulen, R.6
-
91
-
-
84928405266
-
Differential Gene Expression in Liver Tissues of Streptozotocin-Induced Diabetic Rats in Response to Resveratrol Treatment
-
Sadi G, Baloğlu MC, Pektaş MB (2015). Differential Gene Expression in Liver Tissues of Streptozotocin-Induced Diabetic Rats in Response to Resveratrol Treatment. PLoS ONE 10: e0124968.
-
(2015)
PLoS ONE
, vol.10
-
-
Sadi, G.1
Baloğlu, M.C.2
Pektaş, M.B.3
-
93
-
-
84902995501
-
Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk
-
Shen Y-H, Chen S, Peng Y-F, Shi Y-H, Huang X-W, Yang G-H, et al. (2014). Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk. Tumor Biol 35: 4007–4015.
-
(2014)
Tumor Biol
, vol.35
, pp. 4007-4015
-
-
Shen, Y.-H.1
Chen, S.2
Peng, Y.-F.3
Shi, Y.-H.4
Huang, X.-W.5
Yang, G.-H.6
-
94
-
-
33846094030
-
Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol
-
Silan C, Uzun O, Comunoğlu NU, Gokçen S, Bedirhan S, Cengiz M (2007). Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharm Bull 30: 79–83.
-
(2007)
Biol Pharm Bull
, vol.30
, pp. 79-83
-
-
Silan, C.1
Uzun, O.2
Comunoğlu, N.U.3
Gokçen, S.4
Bedirhan, S.5
Cengiz, M.6
-
95
-
-
84900495304
-
Potent inhibitory effect of alpha-viniferin on human cytochrome P450
-
Elsevier Ltd
-
Sim J, Jang HW, Song M, Kim JH, Lee SH, Lee S (2014). Potent inhibitory effect of alpha-viniferin on human cytochrome P450. Food Chem Toxicol 69: 276–280, Elsevier Ltd.
-
(2014)
Food Chem Toxicol
, vol.69
, pp. 276-280
-
-
Sim, J.1
Jang, H.W.2
Song, M.3
Kim, J.H.4
Lee, S.H.5
Lee, S.6
-
96
-
-
84905695534
-
Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways
-
Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, et al. (2014). Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis 35: 1872–1880.
-
(2014)
Carcinogenesis
, vol.35
, pp. 1872-1880
-
-
Singh, B.1
Shoulson, R.2
Chatterjee, A.3
Ronghe, A.4
Bhat, N.K.5
Dim, D.C.6
-
97
-
-
84925680106
-
Resveratrol and cancer: challenges for clinical translation
-
Elsevier B.V
-
Singh CK, Ndiaye M A., Ahmad N (2015) Resveratrol and cancer: challenges for clinical translation. Biochim Biophys Acta - Mol Basis Dis 1852:1178–1185, Elsevier B.V.
-
(2015)
Biochim Biophys Acta - Mol Basis Dis
, vol.1852
, pp. 1178-1185
-
-
Singh, C.K.1
Ndiaye, A.M.2
Ahmad, N.3
-
98
-
-
84909945993
-
Resveratrol as an Inhibitor of Pregnane X Receptor (PXR): another Lesson in PXR Antagonism
-
Smutny T, Pavek P (2014). Resveratrol as an Inhibitor of Pregnane X Receptor (PXR): another Lesson in PXR Antagonism. J Pharmacol Sci 126: 177–178.
-
(2014)
J Pharmacol Sci
, vol.126
, pp. 177-178
-
-
Smutny, T.1
Pavek, P.2
-
99
-
-
84937532659
-
Resveratrol and diabetes: from animal to human studies
-
Elsevier B.V
-
Szkudelski T, Szkudelska K (2015). Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta - Mol Basis Dis 1852: 1145–1154, Elsevier B.V.
-
(2015)
Biochim Biophys Acta - Mol Basis Dis
, vol.1852
, pp. 1145-1154
-
-
Szkudelski, T.1
Szkudelska, K.2
-
100
-
-
84857696377
-
High-throughput library screening identifies two novel NQO1 inducers in human lung cells
-
Tan XL, Marquardt G, Massimi AB, Shi M, Han W, Spivack SD (2012). High-throughput library screening identifies two novel NQO1 inducers in human lung cells. Am J Respir Cell Mol Biol 46: 365–371.
-
(2012)
Am J Respir Cell Mol Biol
, vol.46
, pp. 365-371
-
-
Tan, X.L.1
Marquardt, G.2
Massimi, A.B.3
Shi, M.4
Han, W.5
Spivack, S.D.6
-
101
-
-
84953897365
-
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial
-
Thazhath SS, Wu T, Bound MJ, Checklin HL, Standfield S, Jones KL, et al. (2016). Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. Am J Clin Nutr 103: 66–70.
-
(2016)
Am J Clin Nutr
, vol.103
, pp. 66-70
-
-
Thazhath, S.S.1
Wu, T.2
Bound, M.J.3
Checklin, H.L.4
Standfield, S.5
Jones, K.L.6
-
102
-
-
84928395247
-
CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy
-
Tian D, Hu Z (2014). CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy. Curr Drug Metab 15: 808–817.
-
(2014)
Curr Drug Metab
, vol.15
, pp. 808-817
-
-
Tian, D.1
Hu, Z.2
-
103
-
-
80455143206
-
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans
-
Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, et al. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14: 612–622.
-
(2011)
Cell Metab
, vol.14
, pp. 612-622
-
-
Timmers, S.1
Konings, E.2
Bilet, L.3
Houtkooper, R.H.4
van de Weijer, T.5
Goossens, G.H.6
-
104
-
-
2342516193
-
Human CYP1B1 Is Regulated by Estradiol via Estrogen Receptor
-
Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T (2004). Human CYP1B1 Is Regulated by Estradiol via Estrogen Receptor. Cancer Res 64: 3119–3125.
-
(2004)
Cancer Res
, vol.64
, pp. 3119-3125
-
-
Tsuchiya, Y.1
Nakajima, M.2
Kyo, S.3
Kanaya, T.4
Inoue, M.5
Yokoi, T.6
-
105
-
-
84922420283
-
Modulation of endogenous antioxidant activity by resveratrol and exercise in mouse liver is age dependent
-
Tung BT, Rodríguez-Bies E, Ballesteros-Simarro M, Motilva V, Navas P, López-Lluch G (2013). Modulation of endogenous antioxidant activity by resveratrol and exercise in mouse liver is age dependent. J Gerontol A Biol Sci Med Sci 9: 1–12.
-
(2013)
J Gerontol A Biol Sci Med Sci
, vol.9
, pp. 1-12
-
-
Tung, B.T.1
Rodríguez-Bies, E.2
Ballesteros-Simarro, M.3
Motilva, V.4
Navas, P.5
López-Lluch, G.6
-
106
-
-
84947925857
-
Organ and tissue-dependent effect of resveratrol and exercise on antioxidant defenses of old mice
-
Tung BT, Rodriguez-Bies E, Thanh HN, Le-Thi-Thu H, Navas P, Sanchez VM, et al. (2015). Organ and tissue-dependent effect of resveratrol and exercise on antioxidant defenses of old mice. Aging Clin Exp Res. doi:10.1007/s40520-015-0366-8.
-
(2015)
Aging Clin Exp Res
-
-
Tung, B.T.1
Rodriguez-Bies, E.2
Thanh, H.N.3
Le-Thi-Thu, H.4
Navas, P.5
Sanchez, V.M.6
-
107
-
-
84944790420
-
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
-
Lippincott Williams & Wilkins
-
Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, et al. (2015). A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85: 1383–91, Lippincott Williams & Wilkins.
-
(2015)
Neurology
, vol.85
, pp. 1383-1391
-
-
Turner, R.S.1
Thomas, R.G.2
Craft, S.3
van Dyck, C.H.4
Mintzer, J.5
Reynolds, B.A.6
-
108
-
-
53049083034
-
Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress
-
Upadhyay G, Singh AK, Kumar A, Prakash O, Singh MP (2008). Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. Eur J Pharmacol 596: 146–152.
-
(2008)
Eur J Pharmacol
, vol.596
, pp. 146-152
-
-
Upadhyay, G.1
Singh, A.K.2
Kumar, A.3
Prakash, O.4
Singh, M.P.5
-
109
-
-
84958787579
-
Association between Metabolic Syndrome and Cancer
-
Uzunlulu M, Telci Caklili O, Oguz A (2016). Association between Metabolic Syndrome and Cancer. Ann Nutr Metab 68: 173–179.
-
(2016)
Ann Nutr Metab
, vol.68
, pp. 173-179
-
-
Uzunlulu, M.1
Telci Caklili, O.2
Oguz, A.3
-
110
-
-
9444296057
-
High absorption but very low bioavailability of oral resveratrol in humans
-
Walle T, Hsieh F, Delegge MH, Oatis JE, Walle UK (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab disposition 32: 1377–1382.
-
(2004)
Drug Metab disposition
, vol.32
, pp. 1377-1382
-
-
Walle, T.1
Hsieh, F.2
Delegge, M.H.3
Oatis, J.E.4
Walle, U.K.5
-
111
-
-
84929151344
-
Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways
-
Elsevier Ireland Ltd
-
Wang Y, Jiang Y, Fan X, Tan H, Zeng H, Wang Y, et al. (2015). Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways. Toxicol Lett 236: 82–89, Elsevier Ireland Ltd.
-
(2015)
Toxicol Lett
, vol.236
, pp. 82-89
-
-
Wang, Y.1
Jiang, Y.2
Fan, X.3
Tan, H.4
Zeng, H.5
Wang, Y.6
-
112
-
-
20344364428
-
Metabolism and bioavailability of trans-resveratrol
-
Wenzel E, Somoza V (2005). Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49: 472–481.
-
(2005)
Mol Nutr Food Res
, vol.49
, pp. 472-481
-
-
Wenzel, E.1
Somoza, V.2
-
113
-
-
63849152475
-
Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol
-
van de Wetering K, Burkon A, Feddema W, Bot A, De Jonge H, Somoza V, et al. (2009). Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol. Mol Pharmacol 75: 876–885.
-
(2009)
Mol Pharmacol
, vol.75
, pp. 876-885
-
-
van de Wetering, K.1
Burkon, A.2
Feddema, W.3
Bot, A.4
De Jonge, J.H.5
Somoza, V.6
-
114
-
-
79959797981
-
The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk
-
Williams-Brown MY, Salih SM, Xu X, Veenstra TD, Saeed M, Theiler SK, et al. (2011). The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk. J Steroid Biochem Mol Biol 126: 78–86.
-
(2011)
J Steroid Biochem Mol Biol
, vol.126
, pp. 78-86
-
-
Williams-Brown, M.Y.1
Salih, S.M.2
Xu, X.3
Veenstra, T.D.4
Saeed, M.5
Theiler, S.K.6
-
115
-
-
84901810516
-
Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults
-
Witte AV, Kerti L, Margulies DS, Floel A (2014). Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults. J Neurosci 34: 7862–7870.
-
(2014)
J Neurosci
, vol.34
, pp. 7862-7870
-
-
Witte, A.V.1
Kerti, L.2
Margulies, D.S.3
Floel, A.4
-
116
-
-
84891397021
-
Resveratrol Downregulates Cyp2e1 and Attenuates Chemically Induced Hepatocarcinogenesis in SD Rats
-
Wu X, Li C, Xing G, Qi X, Ren J (2013). Resveratrol Downregulates Cyp2e1 and Attenuates Chemically Induced Hepatocarcinogenesis in SD Rats. J Toxicol Pathol 26: 385–392.
-
(2013)
J Toxicol Pathol
, vol.26
, pp. 385-392
-
-
Wu, X.1
Li, C.2
Xing, G.3
Qi, X.4
Ren, J.5
-
117
-
-
84929838814
-
Mechanisms of estrogen carcinogenesis: the role of E2/E1–quinone metabolites suggests new approaches to preventive intervention – A review
-
Elsevier Inc
-
Yager JD (2015). Mechanisms of estrogen carcinogenesis: the role of E2/E1–quinone metabolites suggests new approaches to preventive intervention – A review. Steroids 99: 56–60, Elsevier Inc.
-
(2015)
Steroids
, vol.99
, pp. 56-60
-
-
Yager, J.D.1
-
118
-
-
80052013737
-
Polyphenols in Alcoholic Beverages Activating Constitutive Androstane Receptor CAR
-
Yao R, Yasuoka A, Kamei A, Kitagawa Y, Rogi T, Taieishi N, et al. (2011). Polyphenols in Alcoholic Beverages Activating Constitutive Androstane Receptor CAR. Biosci Biotechnol Biochem 75: 1635–1637.
-
(2011)
Biosci Biotechnol Biochem
, vol.75
, pp. 1635-1637
-
-
Yao, R.1
Yasuoka, A.2
Kamei, A.3
Kitagawa, Y.4
Rogi, T.5
Taieishi, N.6
-
119
-
-
0037273329
-
Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate
-
Yu C, Shin YG, Kosmeder JW, Pezzuto JM, van Breemen RB (2003). Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate. Rapid Commun Mass Spectrom 17: 307–313.
-
(2003)
Rapid Commun Mass Spectrom
, vol.17
, pp. 307-313
-
-
Yu, C.1
Shin, Y.G.2
Kosmeder, J.W.3
Pezzuto, J.M.4
van Breemen, R.B.5
-
120
-
-
84875211310
-
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of gentic variation
-
Elsevier Inc
-
Zanger UM, Schwab M (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of gentic variation. Pharmacol Ther 138: 103–141, Elsevier Inc.
-
(2013)
Pharmacol Ther
, vol.138
, pp. 103-141
-
-
Zanger, U.M.1
Schwab, M.2
-
121
-
-
71349084966
-
Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers
-
Zendehdel K, Bahmanyar S, McCarthy S, Nyren O, Andersson B, Ye W (2009). Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers. Cancer Causes Control 20: 2031–2038.
-
(2009)
Cancer Causes Control
, vol.20
, pp. 2031-2038
-
-
Zendehdel, K.1
Bahmanyar, S.2
McCarthy, S.3
Nyren, O.4
Andersson, B.5
Ye, W.6
-
122
-
-
84958151676
-
The effect of resveratrol on pharmacokinetics of aripiprazole in vivo and in vitro
-
Taylor & Francis
-
Zhan Y-Y, Liang B-Q, Li X-Y, Gu E-M, Dai D-P, Cai J-P, et al. (2015). The effect of resveratrol on pharmacokinetics of aripiprazole in vivo and in vitro. Xenobiotica 46: 439–444, Taylor & Francis.
-
(2015)
Xenobiotica
, vol.46
, pp. 439-444
-
-
Zhan, Y.-Y.1
Liang, B.-Q.2
Li, X.-Y.3
Gu, E.-M.4
Dai, D.-P.5
Cai, J.-P.6
-
123
-
-
84870690777
-
The role of human aldo-keto reductases in the metabolic activation and detoxication of polycyclic aromatic hydrocarbons: interconversion of PAH catechols and PAH o-quinones
-
NOV
-
Zhang L, Jin Y, Huang M, Penning TM (2012). The role of human aldo-keto reductases in the metabolic activation and detoxication of polycyclic aromatic hydrocarbons: interconversion of PAH catechols and PAH o-quinones. Front Pharmacol NOV3: 1–12.
-
(2012)
Front Pharmacol
, vol.3
, pp. 1-12
-
-
Zhang, L.1
Jin, Y.2
Huang, M.3
Penning, T.M.4
-
124
-
-
16444377083
-
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs
-
Zhou S, Chan SY, Goh BC, Chan E, Duan W, Huang M, et al. (2005). Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44: 279–304.
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 279-304
-
-
Zhou, S.1
Chan, S.Y.2
Goh, B.C.3
Chan, E.4
Duan, W.5
Huang, M.6
-
125
-
-
77951447009
-
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
-
Zhou S-F, Wang B, Yang L-P, Liu J-P (2010). Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 42: 268–354.
-
(2010)
Drug Metab Rev
, vol.42
, pp. 268-354
-
-
Zhou, S.-F.1
Wang, B.2
Yang, L.-P.3
Liu, J.-P.4
-
126
-
-
84937532657
-
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
-
Elsevier B.V
-
Zordoky BNM, Robertson IM, Dyck JRB (2015). Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta - Mol Basis Dis 1852: 1155–1177, Elsevier B.V.
-
(2015)
Biochim Biophys Acta - Mol Basis Dis
, vol.1852
, pp. 1155-1177
-
-
Zordoky, B.N.M.1
Robertson, I.M.2
Dyck, J.R.B.3
|